About this trial
Zenker's diverticulum (ZD) is a rare benign condition, due to an acquired sac-like outpouching of the mucosa and submucosa layers originating from the pharyngoesophageal junction. Endoscopic techniques like flexible endoscopic septum division (FESD) or per-oral endoscopic septotomy (POES), represent a minimally invasive alternative to surgery or to rigid endoscopic procedure to treat ZD. The goal of the research will be to evaluate the safety of the procedures and to measure Zenker-symptom severity in all patients treated by endoscopic procedures.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients with symptomatic ZD treated by endoscopic procedures
Disqualifiers
pregnancy and breastfeeding
Trial population
patients affected by ZD and treated by endoscopic procedures.
Trial design
Cohort
Prospective
Treatments tested in this trial
Endoscopic septotomy
Procedure/SurgeryPatients will be placed in left lateral decubitus position, either in conscious sedation or under deep sedation with propofol or endotracheal intubation.The procedure will be performed with a flexible standard endoscope and started with initial endoscopic examination with suction of possible retained material insidethe diverticulum. An incision of the bridge between the ZD and the esophagus will be done (using one endoscopic procedure as POES or FESD or other)
Treatment groups
Trial outcomes
Primary outcomes
Incidence of Adverse Events
Any complications as bleeding, perforation, others
Secondary outcomes
symptoms after the procedure
The frequency of symptoms such as dysphagia, regurgitation, weight loss
Sponsors and contacts
Click on the lead sponsor to view all of their trials.